Solid Tumours
PANTUMOR-1
A Phase II, multicenter, multi-cohort, open-label trial to evaluate the efficacy and safety of oral zongertinib (BI 1810631) for the treatment of selected HER2-mutated or overexpressed/amplified solid tumors
Trial overview
Clinical Area
Solid Tumours
Disease / Condition
Basket
Study Phase
ll
Trial Identifiers
GenesisCare Location(s)
Principal Investigator(s)